EN  |  DE
Home   |  Kontakt   |  Standorte
Drug Coated Balloon
Home > Services > Events & News > Rückblick 2012

Rückblick 2012

EuroPCR 2012: B. Braun & Bayer Satellite Symposium

“Drug-Coated Balloons: Perspectives in Angioplasty Beyond Stents”

Date & Venue:
Thursday 17th May 2012
12:00 - 13:00 h
Room 352AB
Palais de Congrès, Paris

Bruno Scheller, Juan Granada

  • Understand the concept and the basic principals of the Paccocath balloon coating technology
  • Get an overview and summary of the pre-clinical and clinical drug-coated balloon evaluation for coronary and peripheral applications
  • Learn about the possible coronary and peripheral indications of the SeQuent Please and Cotavance drug-coated balloon technology
  • Learn about procedural treatment recommendations and how the drug-coated balloon should be used to achieve optimal long-term results
  • Get practical tips and tricks for the drug-coated balloon usage

12:00 - 12:05 Uhr
Introduction to the Paccocath® Technology
Juan Granada

12:05 - 12:15 Uhr
Cotavance drug-coated balloon with Paccocath® Technology: What is it and how does it work?
Juan Granada

12:15 - 12:25 Uhr
Further analysis of the THUNDER study: 5-year results and implications for treatment of dissections
Gunnar Tepe

12:25 - 12:35 Uhr
Impact of Cotavance drug-coated balloons on clinical practice: Latest clinical study status and updates
Nicolas Diehm

12:35 - 12:50 Uhr
Comprehensive review of clinical data with the Paccocath® Technology
Bruno Scheller

12:50 - 13:05 Uhr
Drug-coated balloon only: treatment recommendations of the German consensus group and case reports from daily practice with SeQuent® Please
Franz Kleber

13:05 - 13:20 Uhr

13:20 - 13:30 Uhr
Take-home message
Bruno Scheller

2nd International DCB Symposium

German Drug Coated Balloon Consensus Group

Neueste wissenschaftliche und verfahrenstechnische Erkenntnise zum DCB liefert das kommende „2. Internationale DCB Symposium“. Hochrangige Experten aus dem Bereich der interventionellen Angioplastie werden dem Event als Redner beiwohnen und es so zu einem wissenschaftlichen Hot Spot für das „DCB-only“ Konzept machen!

Preliminary Programme
Symposium Website

Programme: Friday, 16 November 2012

Introduction to the meeting: Franz X. Kleber (Berlin/DE) 

15:15 - 16:35

Chair: Bruno Scheller (Homburg, Saar/DE), Jochen Wöhrle (Ulm/DE)

  • Perspectives of angioplasty – the EAPCI view
    Javier Escaned (Madrid/ES)
  • Technology of DCBs
    Juan F. Granada (New York, NY/US)
  • DCB from an Euro PCR perspective
  • From innovation to reimbursement – DCB from AGIKs perspective
    Benny Levenson (Berlin/DE)

16:35 - 17:55
Established Indications I
Chair: Harald Rittger (Erlangen/DE), Juan F. Granada (New York, NY/US)

  • Coronary DCB applications – Future mainstream or niche device?
    Franz X. Kleber (Berlin/DE)
  • In stent restenosis after BMS – long term data
    Bruno Scheller (Homburg, Saar/DE)
  • In stent restenosis after DES
    Harald Rittger (Erlangen/DE)
  • Japanese Experiences
    Seiji Habara (Kurashiki/JP)

17:55 - 18:10
Coffee Break

18:10 - 19:50
Established Indications II
Chair: Tian Hai Koh (Singapore/SG), Leonhard Bruch (Berlin/DE)

  • DCB in South Asia Patients – experiences from a Single center
    Hee Hwa Ho (Singapore/SG)
  • DCB vs POBA vs PES in DES Restenosis
    Adnan Kastrati (Munich/DE)
  • Insights from Optical Coherence Tomography
    Tudor- Constantin Pörner (Jena/DE)
  • Cost-Benefit Analysis of DCB-PCI
    Klaus Bonaventura (Potsdam/DE)
  • The World Wide DCB Registry
    Jochen Wöhrle (Ulm/DE)


Programme: Saturday, 17 November 2012

8:30 - 9:45
Upcoming Indications I
Chair: Bruno Scheller (Homburg, Saar/DE), Fernando Alfonso (Madrid/ES)

  • Drug-coated balloons in conjunction with BMS (Indicor)
    Upendra Kaul (New Delhi/IN)
  • Drug-coated balloons in conjunction with EPC stent
    Jochen Wöhrle (Ulm/DE)
  • The Valentines II Registry
    Ron Waksman (Washington, DC/US)
  • DCB in small vessels
    Bruno Scheller (Homburg, Saar/DE)

09:45 - 10:00
Coffee Break

10:00 - 11:30
Upcoming Indications II
Chair: Stefan Hoffmann (Berlin/DE), Adrian Low (Singapore/SG)

  • Drug-coated balloons in bifurcation lesions
    Detlef Mathey (Hamburg/DE)
  • Comparison between various drug eluting matrices
    Bodo Cremers (Homburg, Saar/DE)
  • Comparison DCB vs DES
    Fernando Alfonso (Madrid/ES)
  • Comparison DCB plus BMS versus DES in CTO
    Jochen Wöhrle (Ulm/DE)
  • DCB only in CTO
    Gerald Werner (Darmstadt/DE)

11:30 - 12:30
Peripheral Use of DCBs
Chair: Michael Werk (Berlin/DE), Jochen Wöhrle (Ulm/DE)

  • Overview on treatment modalities in the peripheral circulation
    Aljoscha Rastan (Bad Krozingen/DE)
  • From FIM trials to clinical routine
    Hans Krankenberg (Hamburg/DE)
  • Clinical evidence of DCB in the peripheral vasculature
    Michael Werk (Berlin/DE)
  • Outlook – the future role of DCB in peripheral vascular disease
    Aljoscha Rastan (Bad Krozingen/DE)

12:30 - 13:00
Lunch Break

13:00 - 14:45
New Developments
Chair: Mohd Ali Rosli (Kuala Lumpur/MY), Franz X. Kleber (Berlin/DE)

  • The risk of dual antiplatelet therapy in conjunction with anticoagulation
    Mariusz Zadura (Karlsburg/DE)
  • Drug-coated balloons for atrial fibrillation patients
    Mariusz Zadura (Karlsburg/DE)
  • Reduced acute thrombosis rates in DCB only PCI
    Klaus Bonaventura (Potsdam/DE)
  • Positive remodeling after DCB
    Franz X. Kleber (Berlin/DE)
    Positive remodeling after bioabsorbable vascular scaffolds
  • Angiosculpt preparation of lesion for DCB PCI and coated AngioSculpt
    Gary Gershony (Walnut Creek, CA/US)
  • Risk of coronary aneurysm formation?
    Franz X. Kleber (Berlin/DE)

14:30 - 15:15
Take home message

  • Consensus Statement Revised
    Bruno Scheller (Homburg/Saar/DE)
  • Farewell
    Franz X. Kleber (Berlin/DE)